An association between plasma free protein s concentration and risk of coronary heart disease in middle-aged men

A R Rudnicka1, G J Miller, T Nelson

  • 1Department of Environmental and Preventive Medicine, St. Bartholomew's and Royal London School of Medicine and Dentistry, London, UK.

Insights

Higher levels of free Protein S, a vitamin K-dependent protein, were linked to an increased risk of coronary heart disease (CHD) in men. This finding suggests a potential role for inflammation in both Protein S levels and CHD development.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Biochemistry

Background:

  • Protein S is a vitamin K-dependent anticoagulant protein.
  • Conflicting reports exist regarding Protein S levels in arterial thrombosis and coronary heart disease (CHD).

Purpose of the Study:

  • To investigate the association between free Protein S levels and the risk of developing CHD.
  • To clarify the relationship between free Protein S and cardiovascular events.

Main Methods:

  • Prospective survey of 3000 men aged 50-61, free of clinical CHD at baseline.
  • Measurement of free Protein S using a commercial immunoassay.
  • Follow-up for CHD events including myocardial infarction, coronary revascularization, and cardiovascular death.

Main Results:

  • A total of 168 CHD events occurred over 21,000 person-years.
  • Mean free Protein S concentration was 6% higher in men who developed CHD.
  • A 1 S.D. increase in free Protein S showed a crude hazard ratio of 1.25 for CHD.
  • Multivariate analysis revealed a borderline significant association (HR 1.15) after adjusting for conventional risk factors.

Conclusions:

  • Elevated free Protein S levels are associated with an increased risk of CHD.
  • This association may be influenced by plaque-destabilizing inflammatory activity.
  • Further research is needed to elucidate the precise role of Protein S in CHD pathogenesis.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...